نتایج جستجو برای: chlorambucil

تعداد نتایج: 2068  

Journal: :iranian journal of cancer prevention 0
mehrdad payandeh 1. pennathur a, gibson mk, jobe ba, luketich jd. oesophageal carcinoma.lancet. 2013;381(9864):400-12. 2. ferlay j, shin hr, bray f, forman d, mathers c, parkin dm.estimates of worldwide burden of cancer in 2008: globocan 2008. int j cancer. 2010;127:2893–917. 3. lepage c, rachet b, jooste v, faivre j, coleman mp. continuing rapid increase in sophageal adenocarcinoma in england and wales. am j gastroentero.l 2008;103 2694–99. 4. pennathur a, farkas a, krasinskas am. esophagectomy for t1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. ann thorac surg. 2009;87:1048–55. 5. mir mr, rajabpour mv, delarestaghi mm, hadji m, harirchi i, mir p, mir a, lashkari m, zendehdel k. short- and long-term survival of esophageal cancer patients treated at the cancer institute of iran. dig surg. 2013;30(4-6):331-6. 6. harirchi i, kolahdoozan s, hajizadeh s, safari f, sedighi z, nahvijou a, mir mr, mousavi sm, zendehdel k. esophageal cancer in iran; a population-based study regarding adequacy of cancer surgery and overall survival. eur j surg oncol. 2014;40(3):352-7. 7. pennathur a, luketich jd. resection for esophageal cancer:strategies for optimal management. ann thorac surg. 2008;85:751–56. 8. pennathur a, zhang j, chen h, luketich jd. the “best operation”for esophageal cancer? ann thorac surg. 2010;89:2163–67. 9. davies ar, forshaw mj, khan aa, noorani as, patel vm, strauss dc, mason rc. transhiatal esophagectomy in a high volume institution. world j surg oncol. 2008 ;6:88. 10. chang ac, ji h, birkmeyer nj, orringer mb, birkmeyer jd. outcomes after transhiatal and transthoracic esophagectomy for cancer. ann thorac surg. 2008;85(2):424-9. 11. nikbakhsh n, amri p, shakeri a, shakeri a. changes in blood pressure and heart rhythm during transhiatal esophagectomy.caspian j intern med. 2012;3(4):541-5. 12. mallipeddi mk, onaitis mw. the contemporary role of minimally invasive esophagectomy in esophageal cancer. curr oncol rep. 2014;16(3):374. 13. sundaram a, geronimo jc, willer bl, hoshino m, torgersen z, juhasz a, lee th, mittal sk. survival and quality of life after minimally invasive esophagectomy: a single-surgeon experience. surg endosc. 2012;26(1):168-76. 14. herbella fa, patti mg. minimally invasive esophagectomy. world j gastroenterol. 2010;16(30):3811-5. 15. rice tw, blackstone eh, rusch vw. 7th edition of the ajcc cancer staging manual: esophagus and esophagogastric junction.ann surg oncol. 2010;17(7):1721-4 16. d'journo xb, thomas pa. current management of esophageal cancer. j thorac dis. 2014;6 suppl 2:s253-64. 17.hoppo t, jobe ba, hunter jg. minimally invasive esophagectomy: the evolution and technique of minimally invasive surgery for esophageal cancer. world j surg. 2011;35(7):1454-63. 18. dhamija a, dhamija a, hancock j, mccloskey b, kim aw, detterbeck fc, boffa dj. minimally invasive oesophagectomy more expensive than open despite shorter length of stay. eur j cardiothorac surg. 2014;45(5):904-9. 19. galvani ca, gorodner mv, moser f, jacobsen g, chretien c, espat nj, donahue p, horgan s. robotically assisted laparoscopic transhiatal esophagectomy. surg endosc. 2008;22(1):188-95. 20. nguyen nt, hinojosa mw, smith br, chang kj, gray j, hoyt d. minimally invasive esophagectomy: lessons learned from 104 operations. ann surg. 2008;248(6):1081-91. 21. dunn dh, johnson em, morphew ja, dilworth hp, krueger jl, banerji n. robot-assisted transhiatal esophagectomy: a 3-year single-center experience. dis esophagus. 2013;26(2):159-66. 22. maas kw, biere ss, scheepers jj, gisbertz ss, van-der-peet dl, cuesta ma. laparoscopic versus open transhiatal esophagectomy for distal and junction cancer. rev esp enferm dig. 2012;104(4):197-202. 23. rizvi fh, rizvi ss, syed aa, khattak s, khan ar. minimally invasive esophagectomy for esophageal cancer: the first experience from pakistan. int j surg oncol. 2014;2014:864705. 24. tabatabaie sa., hashemi sm,, mohajeri gh,ahmadinejad m, goharian v, kolahdoozan m.,sehhat s, davarpanah ah. incidence of hypotension and type of arrhythmia in transhiatal esophagectomy and evaluation of related factors.iranian journal of surgery. 2009;16(4):59-68. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran masoud sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran edris sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran

1. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran 2. students research committee, kermanshah university of medical sciences, kermanshah, iran 3. medical biology research center, kermanshah university of medical sciences, kermanshah, iran                                     corresponding author: masoud sadeghi, msc. tel: (+98) 9185960644 ema...

Journal: :Journal of neurology, neurosurgery, and psychiatry 1995
E Oksenhendler S Chevret J M Léger J P Louboutin A Bussel J C Brouet

The study compared chlorambucil alone with chlorambucil in combination with plasma exchange in patients with polyneuropathy associated with monoclonal IgM. Forty four patients were prospectively randomly assigned, in a comparative open trial, to receive either 0.1 mg/kg/day chlorambucil orally, for 12 months or chlorambucil associated with 15 courses of plasma exchange, during the first four mo...

Journal: :Biomeditsinskaia khimiia 2021

In the present work we have studied a novel conjugate of DNA alkylating agent chlorambucil with podophyllotoxin, ligand colchicine binding site in tubulin. The target compound was obtained by Steglich esterification podophyllotoxin percentage yield 41%. Results biotesting carried out on carcinoma A549 cell line revealed that at concentration 2 μM caused full depolymerization microtubules withou...

Journal: :The New England journal of medicine 2014
Valentin Goede Kirsten Fischer Raymonde Busch Anja Engelke Barbara Eichhorst Clemens M Wendtner Tatiana Chagorova Javier de la Serna Marie-Sarah Dilhuydy Thomas Illmer Stephen Opat Carolyn J Owen Olga Samoylova Karl-Anton Kreuzer Stephan Stilgenbauer Hartmut Döhner Anton W Langerak Matthias Ritgen Michael Kneba Elina Asikanius Kathryn Humphrey Michael Wenger Michael Hallek

BACKGROUND The monoclonal anti-CD20 antibody rituximab, combined with chemotherapeutic agents, has been shown to prolong overall survival in physically fit patients with previously untreated chronic lymphocytic leukemia (CLL) but not in those with coexisting conditions. We investigated the benefit of the type 2, glycoengineered antibody obinutuzumab (also known as GA101) as compared with that o...

2018
Anne-Sophie Michallet Melih Aktan Wolfgang Hiddemann Osman Ilhan Peter Johansson Kamel Laribi Balkis Meddeb Carol Moreno João Raposo Anna Schuh Ali Ünal Tom Widenius Alf Bernhardt Kerstin Kellershohn Dimitri Messeri Stuart Osborne Véronique Leblond

MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chlorambucil in fludarabine-ineligible patients with chronic lymphocytic leukemia. Patients received rituximab plus bendamustine or rituximab plus chlorambucil every four weeks for six cycles. Rituximab plus chlorambucil-treated patients without a complete response after Cycle 6 received chlorambucil mon...

Journal: :Dalton transactions 2015
Alexey A Nazarov Samuel M Meier Olivier Zava Yulia N Nosova Elena R Milaeva Christian G Hartinger Paul J Dyson

Chemotherapeutics for the treatment of tumorigenic conditions that feature novel modes of action are highly sought after to overcome the limitations of current chemotherapies. Herein, we report the conjugation of the alkylating agent chlorambucil to the RAPTA scaffold, a well-established pharmacophore. While chlorambucil is known to alkylate DNA, the RAPTA complexes are known to coordinate to a...

2015
Mehrdad Payandeh Masoud Sadeghi Edris Sadeghi

BACKGROUND Chronic lymphocytic leukemia (CLL) has been the most common type of leukemia in adults worldwide, and then more common in the elderly, markedly more common in patients over the age of 65 years. METHODS Seventy patients with CLL have referred to Clinic of Hematology-Oncology, Kermanshah, Iran, between Jan 2000 and Jun 2014. We have analyzed age, sex, survival, kind of chemotherapy a...

Journal: :Postgraduate medical journal 1979
A Naysmith R H Robson

Introduction Chronic lymphatic leukaemia is a disease of the elderly with a long natural history. Treatment is palliative, with chlorambucil the drug of choice (Livingston and Carter, 1970). The recognized side effects of chlorambucil include nausea, myelosuppression, skin eruptions and pulmonary fibrosis (Stenfert Kroese, 1975), but their incidence is low. Although high doses of chlorambucil a...

2014
Ebenezer Tunde Olayinka Ayokanmi Ore

Chlorambucil (4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid) is an alkylating agent, indicated in chronic lymphocytic leukaemia. Kolaviron (KV), a biflavonoid complex from Garcinia kola, and L-ascorbic acid (AA) are known to protect against oxidative damage in vivo. This study evaluates the protective capacity of KV and AA on chlorambucil-induced oxidative stress in the testes of rat. Twen...

Journal: :Cancer research 1992
J L Holley A Mather R T Wheelhouse P M Cullis J A Hartley J P Bingham G M Cohen

Many tumor cells, including murine ADJ/PC6 plasmacytoma cells, possess an active energy dependent polyamine uptake system which selectively accumulates endogenous polyamines and structurally related compounds. We have attempted to target the cytotoxic drug chlorambucil to a tumor possessing this uptake system by conjugating it to the polyamine spermidine. Furthermore, since polyamines have a hi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید